Sign in

You're signed outSign in or to get full access.

Benjamin Cross

Director at Jushi Holdings
Board

About Benjamin Cross

Independent director of Jushi Holdings Inc. (JUSHF) since 2019; age 70; resident of Connecticut. Cross spent 20 years at Morgan Stanley’s Commodities division (London and New York), retiring as Managing Director in 2015; prior roles at Merrill Lynch and a commodities exchange. He holds a BS from Cornell University and previously served as a Board Advisor to Ursa Space. The board identifies him for financial markets and commodities expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
Morgan Stanley (Commodities)Managing Director20 years; retired 2015Senior leadership in commodities trading/markets
Merrill LynchCommodities-related roleNot disclosedFinancial markets experience
Commodities ExchangePrior roleNot disclosedMarket operations context

External Roles

OrganizationRoleTenureNotes
Ursa SpaceBoard AdvisorNot disclosedGeospatial intelligence; oil inventories focus

Board Governance

  • Independence: Cross is independent under Canadian NI 52-110; one of four independent directors on a five-member board .
  • Committee assignments: Audit Committee member (Chair: Billy Wafford); Compensation Committee member (Chair: CEO James Cacioppo); Nominating & Corporate Governance Committee member (Chair: CEO James Cacioppo) .
  • Attendance: In 2024, each director attended at least 75% of Board and committee meetings on which they served (except CEO recused from certain compensation meetings) .
  • Lead Independent Director: Stephen Monroe; independent executive sessions occur during regular meetings .
CommitteeRole2024 MeetingsIndependence Note
AuditMember4All members independent and financially literate under NI 52-110
CompensationMember3Chair is the CEO; Cross and Monroe independent members
Nominating & Corporate GovernanceMember0Chair is the CEO; Cross and Monroe independent members

Fixed Compensation

YearAnnual Retainer (Cash)Committee Chair FeesMeeting FeesNotes
2024$70,000 None (not a chair) Not disclosed Directors reimbursed for travel expenses

Performance Compensation

Time-based equity; no director-specific performance metrics disclosed. In 2024, Jushi implemented a director option cancellation and regrant program; Cross elected to participate. Replacement options vest one year from grant (Sept 13, 2024) at $0.54 exercise price (fair market value on grant date) .

Grant/ActionDateInstrument# OptionsExercise PriceVestingGrant-Date FV (USD)
Option cancellation & regrant (directors aggregate)2024-09-13Stock options394,758 (aggregate for all non-employee directors) $0.54 1-year cliff from grant date
Cross—Option awards (reported value)2024Stock optionsNot individually disclosed$9,600 (grant-date FV per ASC 718)

Note: Equity awards for non-employee directors in 2024 are time-based, not tied to specific revenue/EBITDA/TSR metrics in the proxy disclosures .

Other Directorships & Interlocks

  • No other public company directorships disclosed in biography; prior advisory role at Ursa Space (private) .
  • Compensation Committee Interlocks: The proxy notes “certain transactions” involving Cacioppo, Cross, and Monroe disclosed elsewhere; no specific related-party transactions for Cross beyond director options program are enumerated in the RPT section .

Expertise & Qualifications

  • Financial markets and commodities expertise; 20-year MD tenure at Morgan Stanley .
  • Financial literacy acknowledged via Audit Committee membership; Audit Committee composed entirely of independent, financially literate members .
  • Education: BS, Cornell University .

Equity Ownership

HolderBeneficial SharesExercisable Options (≤60 days)% of Shares OutstandingOutstanding Options (Total)
Benjamin Cross419,080 180,000 <1% 260,000 (vested + unvested as of 12/31/24)
  • Anti-hedging and anti-pledging policy: Directors prohibited from hedging or pledging company stock .
  • Ownership guidelines: Not disclosed in proxy .

Governance Assessment

  • Strengths:

    • Independent director with deep commodities and capital markets background; contributes to Audit oversight and compensation/nominating processes .
    • Audit Committee exclusively independent and financially literate; external auditor oversight and pre-approval policies described .
    • Anti-hedging/anti-pledging policy supports alignment with shareholders .
  • Concerns / RED FLAGS:

    • Option repricing program included non-employee directors; replacement options at $0.54 reset vesting—often viewed as investor-unfriendly unless clearly performance-linked .
    • Absence of formal written related-party transaction (RPT) policy; reliance on Audit Committee and Board review, with intent to adopt a formal policy later .
    • CEO is both Chair and Chair of Compensation and Nominating Committees, concentrating power; compensatory matters handled with CEO recusal but structural risk persists .
    • Nominating & Corporate Governance Committee did not meet in 2024, potentially indicating limited formal governance refresh activity .
    • Historical 2021 management cease-trade order (auditor timing issue); Cross was on the board at issuance; not ongoing, but indicates prior reporting control challenges .
  • Engagement:

    • Cross met the ≥75% attendance threshold for Board and committees in 2024 .
    • Independent directors hold executive sessions during regular meetings .
  • Related-party exposure (company-level):

    • 2024/2025 financings involved entities affiliated with the CEO and a founder; Audit Committee/Board applied MI 61-101 processes and separate approvals excluding insiders, but formal RPT policy remains pending .

Overall: Cross provides credible financial oversight and independent perspective, but governance optics are weakened by option repricing for directors, concentrated committee chairing by the CEO, and the lack of a formalized RPT policy. Ongoing monitoring of committee activity and future adoption of formal RPT procedures is recommended .